We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-10.00 | -0.64% | 1,541.00 | 1,539.00 | 1,541.00 | 1,553.00 | 1,520.00 | 1,520.00 | 25,934 | 11:43:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.09B | 2M | 0.0148 | 1,045.95 | 2.09B |
Date | Subject | Author | Discuss |
---|---|---|---|
12/3/2024 09:51 | Jeffries has also raised its target from 2165p to 2390p | casholaa | |
12/3/2024 09:34 | Reports of quite a positive write up in the US Journal of Clinical Pharmacology on OPVEE® which apparently rapidly reverses opioid-induced respiratory depression, which is the major cause of deaths due to opioid overdose.Might have thought the Company would get it more publicity. Last results presentation talked of Opvee $150 -$250m potential revenue so will be nice to see in time. | gregmorg | |
04/3/2024 11:28 | Well we're still close to the update that just passed so you'd think if there was an iceberg they'd have told us. Without more I'm just going to proceed on basis of market fluctuations for whatever reason. | casholaa | |
04/3/2024 10:58 | Blue finish anyone? | pngasef | |
04/3/2024 08:35 | US close price of $23 is £18.16 so almost 10% difference to U.K. price now. Looks like the gap is closing though. Some idiot got robbed this morning I think | youngers | |
04/3/2024 08:32 | I think that it depends on whether there are any limit orders below or not and whether they get lowered. I think that, that's how flashes like this occur. | casholaa | |
04/3/2024 08:29 | Strange open today. US closed about 50p up so this then goes down on no news? | youngers | |
01/3/2024 15:57 | Such beautiful price action here. This is such a cash cow of a company....assuming we have no further litigation, the sky is the limit! | pngasef | |
29/2/2024 08:49 | That's that concluded then. | casholaa | |
23/2/2024 12:58 | USD 1093m / 365 averages out to a daily average NR of 2,994,520 per day. Based off the same numbers we should in theory at the end of today, have a further USD 68,873,960 in the coffers? | casholaa | |
23/2/2024 12:05 | 😂😂 | youngers | |
23/2/2024 11:56 | Of course he's a lefty, I doubt he joined labour because he dislikes the Tories, he joined because he's a lefty. He even has that labourer look about him and the blocked nose. He also comes across as blank in the brain and looks a bit like Reg Barney from On the Buses | casholaa | |
23/2/2024 11:51 | I totally agree with that. But changes of power in U.K. only happen rarely and there is the risk of a hung parliament and chaos if labour fluff it. There’s also the risk starmer is much more far left than he’s letting on Clear up those two issues and the political risk falls materially | youngers | |
23/2/2024 11:45 | Nahhh. The difference between cons and labs is where to allocate around 5% of public spending and whether to focus on touch-feely social matters or balance sheet matters. They aren't much different, it's mainly window dressing. | casholaa | |
23/2/2024 11:27 | If in doubt blame brexit eh? The company doesn’t do business in the U.K. its all currently in US so it’s not escaping anything Other than the ridiculously undervalued U.K. stock market Once we have a clean change of government and a sensible first budget I expect a material U.K. revaluation. | youngers | |
23/2/2024 11:13 | Getting out of brexit basket case U.K. with a US listing will be worth a 30/40 pc share price rise and also gives dollar protection as sterling now in perma-decline, good move. | porsche1945 | |
22/2/2024 16:30 | Hang on a minute. The figures were to 31st December, we're now 3rd week of Feb. Even now, let alone end of March I'd expect we've got a lot more money? | casholaa | |
22/2/2024 15:10 | In fairness to them, they've hived off money for the litigation so it doesn't distort net cash, they recognize that it's mainly a US market-driven company with mainly US investors, they are expanding globally, they are not a one-trick pony, they have been succeeding on the revenue front and return value to shareholders through buybacks for the time being. *they also pointed out that they only recently started sales through pharmacy/private doctor dispensers *global company in the making, we just happen to be poorer than our US counterparts | casholaa | |
22/2/2024 14:59 | well ,the webcast was fine, quite upbeat with nice projections and hopes but proof ,as always, will be in the numbers and potential AS SEEN by shareholders. US primary listing sounds really good (that is where their profile and main market is after all, and probably in time that will be highly rewarding, but that also requires getting the investment message across. I am not so sure the company has really succeeded with getting that message across in recent time. Still, am still here for the LT. | gregmorg | |
22/2/2024 13:54 | FT now reporting on us listing | youngers | |
22/2/2024 13:38 | Over 50% shareholders are US based vs over 30% UK. (US markets open in 52 minutes - 14:30 GMT) | casholaa | |
22/2/2024 13:34 | Beat 80% gross margin and expect it to continue. | casholaa | |
22/2/2024 13:31 | USD$415 set aside in escrow for litigated pay-offs. (not part of the cash & investments) | casholaa |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions